Franco Valle - Net Worth and Insider Trading
Franco Valle Net Worth
The estimated net worth of Franco Valle is at least $298,350 dollars as of 2024-11-29. Franco Valle is the CFO of Biomea Fusion Inc and owns about 42,500 shares of Biomea Fusion Inc (BMEA) stock worth over $298,350. Franco Valle is also the Senior Vice President, Finance of Eidos Therapeutics Inc and owns about 0 shares of Eidos Therapeutics Inc (EIDX) stock worth over $0. Details can be seen in Franco Valle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Franco Valle has not made any transactions after 2024-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Franco Valle
Franco Valle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Franco Valle owns 3 companies in total, including Eidos Therapeutics Inc (EIDX) , Iovance Biotherapeutics Inc (IOVA) , and Biomea Fusion Inc (BMEA) .
Click here to see the complete history of Franco Valle’s form 4 insider trades.
Insider Ownership Summary of Franco Valle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIDX | Eidos Therapeutics Inc | 2021-01-12 | Senior Vice President & Finance |
| IOVA | Iovance Biotherapeutics Inc | 2016-08-22 | Principal Accounting Officer |
| BMEA | Biomea Fusion Inc | 2024-06-11 | Chief Financial Officer |
Franco Valle Latest Holdings Summary
Franco Valle currently owns a total of 2 stocks. Among these stocks, Franco Valle owns 42,500 shares of Biomea Fusion Inc (BMEA) as of June 11, 2024, with a value of $298,350 and a weighting of 100%. Franco Valle also owns 0 shares of Eidos Therapeutics Inc (EIDX) as of January 12, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Franco Valle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMEA | Biomea Fusion Inc | 2024-06-11 | 42,500 | 7.02 | 298,350 |
| EIDX | Eidos Therapeutics Inc | 2021-01-12 | 0 | 122.21 | 0 |
Holding Weightings of Franco Valle
Franco Valle Form 4 Trading Tracker
According to the SEC Form 4 filings, Franco Valle has made a total of 3 transactions in Biomea Fusion Inc (BMEA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biomea Fusion Inc is the acquisition of 12,509 shares on June 11, 2024, which cost Franco Valle around $55,415.
According to the SEC Form 4 filings, Franco Valle has made a total of 6 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Eidos Therapeutics Inc is the sale of 3,247 shares on January 12, 2021, which brought Franco Valle around $407,563.
Insider Trading History of Franco Valle
- 1
Franco Valle Trading Performance
GuruFocus tracks the stock performance after each of Franco Valle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Franco Valle is 16.03%. GuruFocus also compares Franco Valle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Franco Valle within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Franco Valle's insider trading performs compared to the benchmark.
Performance of Franco Valle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.66 | | | | | |
| Relative Return to S&P 500(%) | -12.6 | | | | | |
Franco Valle Ownership Network
Franco Valle Owned Company Details
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
Franco Valle is the Senior Vice President & Finance of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Chief Business Officer Cameron Turtle , and See Remarks Jonathan C Fox .
Eidos Therapeutics Inc (EIDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc (EIDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc (EIDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc (EIDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
Franco Valle Mailing Address
Above is the net worth, insider trading, and ownership report for Franco Valle. You might contact Franco Valle via mailing address: 999 Skyway Road, Suite 150, San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
